CompaniesByCap
DNLI
Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare

Denali Therapeutics Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue00330.5M105.1M48.7M335.6M26.3M129.1M00
Gross Profit
Profitability
Operating Income-555.3M-487.3M-196.7M-340.7M-295.8M62.7M-213.2M-46.4M-90.1M-87.4M
EBITDA-544.2M-479.5M-180.0M-330.4M-287.2M71.2M-205.2M-39.0M-87.1M-86.0M
Net Income-512.5M-422.8M-145.2M-326.0M-290.6M71.1M-197.6M-36.2M-88.2M-86.7M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)173M164M137M126M122M113M96M93M87M

Denali Therapeutics Inc. Income Statement — FAQ

Denali Therapeutics Inc. (DNLI) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DNLI's income statement history?

The chart and table above show Denali Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.